Navigation Links
Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness
Date:10/16/2007

as well tolerated. No serious treatment emergent adverse events were reported during the study. The majority of adverse events reported were mild and infrequent. The most common adverse events were dizziness, headache and somnolence and the percentage of patients reporting these events is shown in the table below:

Treatment emergent Placebo EVT 201 EVT 201

adverse events

1.5 mg 2.5 mg

(n=44) (n=53) (n=52)

Dizziness 0 5.7% 9.6%

Headache 0 9.4% 5.8%

Somnolence 2.3% 1.9% 11.5%

No significant difference was seen between either dose of EVT 201 and placebo in the Benzodiazepine Withdrawal Questionnaire.

The results of this study confirm the effects of EVT 201 on sleep onset and sleep maintenance seen in the adult population in Study 2004 and indicate that the same doses 1.5 mg and 2.5 mg have hypnotic efficacy in the elderly with no significant residual effects.

Further analysis of the remaining secondary and exploratory endpoints is ongoing.

"We're delighted that these results in elderly insomniacs again confirm the excellent profile of EVT 201 as a potential treatment that helps patients to fall asleep quickly, maintains their sleep throughout the night and yet enables them to wake in the morning without hangover effects and feeling like they've had a good night's sleep," said Dr John Kemp, Chief Research & Development Officer, Evotec AG. "Due to its partial positive allosteric modulation of GABAA receptors, EVT 201 provides a novel approach to the treatment of insomnia, yet since the GABAA system is a well understood pathway, the risk of unexpected side effect findings are low compared to completely novel mechanisms."

Jorn Aldag, President and Chief Executive Officer, Evotec AG, said: "The positive outcome of this second clinical
'/>"/>

SOURCE Evotec AG
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Autopsy reports could be valuable and informative
2. China reports declining number of SARS Cases
3. Russia Reports First SARS Case
4. Research reports that c-section deliveries are rising
5. Jharkhand reports 13,000 Malaria cases
6. Uganda Reports Failure To Contain Sleeping Sickness
7. WHO reports 36 million deaths world wide due to chronic diseases
8. Reports of Hantavirus infection in India raise concerns
9. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
10. China Reports Yet Another Bird Flu Case
11. China reports seventh bird flu victim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Global Health Innovative Technology Fund (GHIT Fund), a ... know-how and investment to the global fight against ... US$15.3 million to speed the development of promising ... dengue and Chagas disease. The announcement marks the ... November 2013totaling $33.5 millionaimed at diseases that sicken ...
(Date:9/15/2014)... September 15, 2014 Ondine Biomedical ... Loebel, its President and Chief Technology Officer, will ... Photodynamic Therapy (PDT) and Photodiagnosis in Clinical Practice. ... Brixen/Bressanone (Italy) from October 14-18, 2014 alongside the ... on October 13-14th, is an annual conference at ...
(Date:9/15/2014)... VA (PRWEB) September 15, 2014 ... and management consulting services to the federal government, ... in Alexandria, Virginia and Atlanta, Georgia to better ... catalyst for this expansion is credited to the ... in the core areas of management consulting, agile ...
(Date:9/15/2014)... out of every 40 individuals in the United States is ... (SMA), a neurodegenerative disease that causes muscles to weaken over ... a recent breakthrough with the development of a new compound ... disease. In April, a patent was filed for the compound ... using to fight SMA is to ,repress the repressor," said ...
(Date:9/15/2014)... In order to provide predictability and safety, the ... quantify, define and model medical practice. Defined as Bioinformatics ... medical care. , The Journal of BioAcoustic Biology ( ... non-profit Institute of BioAcoustic Biology, located in Albany, Ohio, ... much more than a measurement tool; math, as frequency, ...
Breaking Medicine News(10 mins):Health News:Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases 2Health News:Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases 3Health News:Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases 4Health News:Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases 5Health News:Ondine Presenting at the 2014 International Symposium on Photodynamic Therapy and Photodiagnosis 2Health News:Octo Consulting Group Announces it is Opening Two New Offices in Alexandria, Virginia and Atlanta, Georgia to Better Serve Existing and Future Federal Government Clients 2Health News:Researcher develops and proves effectiveness of new drug for spinal muscular atrophy 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 3
... survival rate of non-small-cell lung cancer patients after ... Cisplatin is an anti-neoplastic medication that interferes with ... growth and spread in the body. ... three or four cycles of cisplatin-based chemotherapy or ...
... the world's first epilepsy drug, an Australian neurologist says.// ... a mild sedative, taken either as a herbal infusion ... form. ,But the Italian author Fabio Colonna first ... botanical work Phytobasanos. ,Colonna said he had controlled ...
... around 700,000 people researchers say dads who have children ... // for developing schizophrenia later in life. ... to the hospital in Sweden between 1989 and 2001 ... Researchers say they found a strong association between the ...
... recent study shows that people who use stomach-acid suppressive ... may be at an increased risk of developing pneumonia ... the stomach can increase vulnerability to infections, as stomach ... Researchers studied pneumonia rates of more than 364,000 patients ...
... study researchers say they have found that the drug ... cancer // decreased patients' cancer incidence after 12 months ... some impact, but the 20-milligram dose had the greatest ... prostatic intraepithelial neoplasia, characterized by abnormal cells in the ...
... New research shows that sleep disorders may be linked ... ADD ), // neuromuscular conditions, and psychiatric problems. ... patients with sleep apnea also had ADD. Results also ... insomnia. Further testing showed some of these patients also ...
Cached Medicine News:Health News:Valerian was first epilepsy drug 2
(Date:9/15/2014)... , Sept. 15, 2014 /PRNewswire-iReach/ -- Asthma ... persons of all ages, but most commonly starts ... characterized by narrowing of the airways, leading to ... lungs come into contact with endogenous and exogenous ... events, such as swelling of the airways, tightening ...
(Date:9/15/2014)... MedicOne Medical Response, a leading provider emergency and ... Inc. Magazine as one of the fastest growing ... - http://photos.prnewswire.com/prnh/20140914/145997 The ... with the largest revenue growth between 2010 and ... ambulance companies to make the list, achieved an ...
(Date:9/15/2014)... -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ... 2014, regular quarterly dividend payment of $0.15 per share ... September 5, 2014, the record date. About ... of patents and royalty assets, consisting primarily of its ... with various biotechnology and pharmaceutical companies. PDL pioneered the  ...
Breaking Medicine Technology:Asthma Market to Reach 161.02 million Cases in 10MM by 2023 2Asthma Market to Reach 161.02 million Cases in 10MM by 2023 3Asthma Market to Reach 161.02 million Cases in 10MM by 2023 4Asthma Market to Reach 161.02 million Cases in 10MM by 2023 5MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 2MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 3PDL BioPharma Completes Regular Quarterly Dividend Payment 2
... , June 21 ViroPharma Incorporated (Nasdaq: ... Cinryze™ (C1 Esterase Inhibitor [Human]) manufacturing expansion activities.   , ... ViroPharma ...  The first project, the parallel chromatography process, was implemented earlier ...
... , MISGAV, Israel , ... of laparoscopic soft tissue prosthetic placement,technologies, today announced that it ... an innovative laparoscopic,surgical instrument that enables accurate and rapid delivery ... including laparoscopic,ventral hernia repair (LVHR). , ...
Cached Medicine Technology:ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 2ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 3ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 4ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 5ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 6PolyTouch Medical Ltd. Receives FDA Clearance to Commercialize PatchAssist(TM) - an Innovative Surgical Instrument Intended to Facilitate the Delivery of Soft Tissue Prosthetics During the Laparoscopic Repair of Soft Tissue Defects 2PolyTouch Medical Ltd. Receives FDA Clearance to Commercialize PatchAssist(TM) - an Innovative Surgical Instrument Intended to Facilitate the Delivery of Soft Tissue Prosthetics During the Laparoscopic Repair of Soft Tissue Defects 3
...
...
... exercise BP monitor is designed to automatically ... diastolic BP along with heart rate. It's ... use in treadmill, ergometer and pharmacological stress ... use in research environments., ,Tango excels ...
...
Medicine Products: